Madrigal Pharmaceuticals, Inc. (MDGL)
534.04
+0.92
(+0.17%)
USD |
NASDAQ |
Sep 11, 16:00
534.04
0.00 (0.00%)
After-Hours: 16:54
Madrigal Pharmaceuticals Gross Profit (TTM) : 1.173B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.173B |
| March 31, 2026 | 1.052B |
| December 31, 2025 | 900.75M |
| September 30, 2025 | 704.02M |
| June 30, 2025 | 494.96M |
| March 31, 2025 | 305.33M |
| December 31, 2024 | 172.80M |
| September 30, 2024 | 73.15M |
| June 30, 2024 | 13.29M |
| March 31, 2024 | -0.571M |
| December 31, 2023 | -0.527M |
| September 30, 2023 | -0.514M |
| June 30, 2023 | -0.50M |
| March 31, 2023 | -0.484M |
| December 31, 2022 | -0.467M |
| September 30, 2022 | -0.444M |
| June 30, 2022 | -0.42M |
| March 31, 2022 | -0.399M |
| December 31, 2021 | -0.405M |
| September 30, 2021 | -0.415M |
| June 30, 2021 | -0.433M |
| March 31, 2021 | -0.459M |
| December 31, 2020 | -0.471M |
| September 30, 2020 | -0.383M |
| June 30, 2020 | -0.296M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.209M |
| December 31, 2019 | -0.112M |
| September 30, 2019 | -0.109M |
| June 30, 2019 | -0.105M |
| March 31, 2019 | -0.101M |
| December 31, 2018 | -0.096M |
| September 30, 2018 | -0.131M |
| June 30, 2018 | -0.116M |
| March 31, 2018 | -0.10M |
| December 31, 2017 | -0.077M |
| September 30, 2017 | -0.017M |
| June 30, 2017 | -0.008M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -0.168M |
| December 31, 2015 | -0.337M |
| September 30, 2015 | -0.506M |
| June 30, 2015 | -0.673M |
| March 31, 2015 | -0.674M |
| December 31, 2014 | -0.673M |
| September 30, 2014 | -0.647M |
| June 30, 2014 | -0.628M |
| March 31, 2014 | -0.459M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Exelixis, Inc. | 2.350B |
| United Therapeutics Corp. | 2.717B |
| Karyopharm Therapeutics, Inc. | 140.44M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |